The global oligonucleotide synthesis market is a dynamic sector within the biotechnology and pharmaceutical industries, primarily focused on the production of custom DNA and RNA sequences. Oligonucleotides serve critical roles in various applications, such as gene synthesis, PCR, and RNA interference. The market involves the synthesis of short nucleic acid sequences, tailored to specific research and diagnostic needs. Key players in the industry offer a range of services, including DNA and RNA oligonucleotide synthesis, purification, and modification. As research in fields such as synthetic biology and gene editing expands, the global oligonucleotide synthesis market remains a crucial enabler of progress in life sciences.
Access Full Report at https://databridgemarketresearch.com/reports/global-oligonucleotide-synthesis-market
Data Bridge Market Research analyzes that the Global Oligonucleotide Synthesis Market which was USD 7.70 billion in 2022, is expected to reach USD 16.36 billion by 2030, and is expected to undergo a CAGR of 11.8% during the forecast period 2023 to 2030. The surge in personalized medicine fuels the global oligonucleotide synthesis market, as healthcare prioritizes individualized treatments. Oligonucleotides play a pivotal role in tailoring therapies to unique genetic profiles, aligning with the industry's push for precision medicine, and driving increased demand and market expansion.
Key Findings of the Study
Rising interest in synthetic biology is expected to drive the market's growth rate
A surge in synthetic biology applications, notably gene synthesis and editing, propels the global oligonucleotide synthesis market. The heightened interest in manipulating and creating biological systems necessitates custom oligonucleotides for precise genetic engineering. As researchers and industries delve deeper into synthetic biology's possibilities, the demand for tailored oligonucleotides rises, fostering substantial market expansion to meet the evolving needs of this innovative and transformative field.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Oligonucleotide, Reagents, and Equipment), Type (Custom Oligos and Predesigned Oligos), Application (Therapeutic Applications, Diagnostics, Research, and Others), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, and others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa
|
|
Market Players Covered
|
Agilent Technologies, Inc. (U.S.), Atdbio Ltd.(U.K.), LGC Limited (U.K.), Bio-Synthesis Inc.(U.S.), Eurofins Genomics (India), Kaneka Eurogentec S.A.(Belgium), General Electric (U.S.), Genscript (U.S.), AJINOMOTO CO., INC (Genedesign, Inc.) (Tokyo), Danaher (U.S.), Merck Kgaa (Germany)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global oligonucleotide synthesis market is segmented on the basis of product, type, application, and end user.
- On the basis of product, the global oligonucleotide synthesis market is segmented into oligonucleotide, reagents, and equipment
- On the basis of type, the global oligonucleotide synthesis market is segmented into custom oligos and predesigned oligos
- On the basis of application, the global oligonucleotide synthesis market is segmented into therapeutic applications, diagnostics, research, and others
- On the basis of end user, the global oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and others
Major Players
Data Bridge Market Research recognizes the following companies as the major global oligonucleotide synthesis market players in global oligonucleotide synthesis market are Eurofins Genomics (India), Kaneka Eurogentec S.A (Belgium), General Electric (U.S.), Genscript (U.S.), AJINOMOTO CO., INC (Genedesign, Inc.) (Tokyo), Danaher (U.S.), Merck Kgaa (Germany)
Market Developments
- In July 2022, WuXi STA, a subsidiary of WuXi AppTec, inaugurated a state-of-the-art large-scale oligonucleotide and peptide manufacturing facility at its Changzhou campus. This strategic expansion significantly bolsters WuXi STA's capacity and capabilities, positioning it to address the escalating global demand for oligonucleotide and peptide therapeutics development and manufacturing. The new facility underscores WuXi STA's commitment to meeting the evolving needs of customers worldwide in the dynamic field of oligonucleotide and peptide-based therapeutic advancements
- In April 2022, Bachem initiated a strategic collaboration with Eli Lilly & Company, focusing on the development and manufacturing of active pharmaceutical ingredients derived from oligonucleotides—a burgeoning class of complex molecules. The collaboration entails Bachem contributing specialized engineering infrastructure and expertise to implement Lilly's innovative oligonucleotide manufacturing technology. This collaboration signifies a concerted effort between the two entities to advance capabilities in the production of cutting-edge pharmaceuticals within the evolving landscape of oligonucleotide-based therapeutics
- In September 2021, SpeeDx made strategic investments in local oligonucleotide manufacturing, aiming to mitigate supply chain risks and bolster sovereign capacity for critical diagnostics. This initiative is poised to enhance oligonucleotide adoption in drug development, subsequently driving market growth. By fortifying domestic production capabilities, SpeeDx contributes to a more resilient and self-sufficient supply chain, aligning with broader industry trends that anticipate increased reliance on oligonucleotides for advancing drug development during the forecast period
Regional Analysis
Geographically, the countries covered in the global oligonucleotide synthesis market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa
As per Data Bridge Market Research analysis:
North America is the dominant region in the global oligonucleotide synthesis market during the forecast period 2023-2030
North America dominates the global oligonucleotide synthesis market due to its robust healthcare infrastructure, a concentration of major market players, a surge in viral diseases, and a growing number of research endeavors. With a well-established foundation in healthcare facilities, the region serves as a hub for advancements, positioning North America at the forefront of oligonucleotide synthesis. The prevalence of viral diseases and extensive research activities further solidify its leadership in driving innovation and market growth.
Asia-Pacific is estimated to be the fastest-growing region in the global oligonucleotide synthesis market during the forecast period 2023-2030
Asia-Pacific is expected to dominate the global oligonucleotide synthesis market from 2023 to 2030. This leadership is driven by increased government initiatives promoting awareness, a surge in research activities, vast untapped markets, a substantial population pool, and rising demands for quality healthcare in the region. These factors position Asia-Pacific as a key player in the expanding oligonucleotide synthesis market, reflecting the region's dynamic contributions to advancements in genomics, healthcare, and life sciences.
For more detailed information about the global oligonucleotide synthesis market report, click here – https://www.databridgemarketresearch.com/reports/global-oligonucleotide-synthesis-market
